e-learning
resources
Berlin 2001
Sunday 23.09.2001
New insights in viral and bacterial lung infection in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cromoglycate in the treatment of respiratory syncytial virus (RSV) bronchiolitis
J. W. M. Troe, A. J. Stuiver, A. V. V. D. Ende-Leemereise, F. G. A. Versteegh (Gouda, The Netherlands)
Source:
Annual Congress 2001 - New insights in viral and bacterial lung infection in children
Session:
New insights in viral and bacterial lung infection in children
Session type:
Poster Discussion
Number:
1133
Disease area:
Airway diseases, Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. W. M. Troe, A. J. Stuiver, A. V. V. D. Ende-Leemereise, F. G. A. Versteegh (Gouda, The Netherlands). Cromoglycate in the treatment of respiratory syncytial virus (RSV) bronchiolitis. Eur Respir J 2001; 16: Suppl. 31, 1133
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Interleukin-9 in severe respiratory syncytial virus (RSV) bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Bronchiolitis
Source: Respipedia Article
Year: 2017
DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2001; 18: 734-737
Year: 2001
Dual infection of infants by human metapneumovirus (hMPV) and human respiratory syncytial virus (hRSV) is strongly associated with severe bronchiolitis
Source: Annual Congress 2004 - Viral bronchiolitis in children: what's new in diagnosis and treatment?
Year: 2004
Respiratory syncytial virus (RSV) prophylaxis in special populations
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011
Increasing severity of bronchiolitis in children with respiratory syncytial virus A ON1
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
The role of viruses in chronic bronchitis and exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 68-75
Year: 2013
Are infants with respiratory syncytial virus (RSV) bronchiolitis different from infants with non RSV bronchiolitis for the development of wheezing in the first year of life?
Source: Eur Respir J 2005; 26: Suppl. 49, 27s
Year: 2005
Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants
Source: Eur Respir J 2014; 44: 666-674
Year: 2014
Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity
Source: Annual Congress 2006 - Virus-induced respiratory tract infection
Year: 2006
Prevalence of respiratory syncytial virus infection among Philippino children with bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 17s
Year: 2002
Interleukin 9 concentration in infants with respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2005; 26: Suppl. 49, 28s
Year: 2005
Montelukast is not preventing reactive airway disease in post respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2006; 28: Suppl. 50, 757s
Year: 2006
Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Source: Eur Respir J 2001; 18: 1044-1058
Year: 2001
Reduced interferon-gamma concentration in infants with severe respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2005; 26: Suppl. 49, 27s
Year: 2005
Human neutrophil elastase (HNE) in acute bronchiolitis
Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Year: 2006
Respiratory infections in children: from respiratory syncytial virus to tuberculosis
Source: International Congress 2019 – Paediatric Year in review
Year: 2019
Interferon induced gene expression in cells from nasal aspirates of infants with bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity
Year: 2007
Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy
Source: Eur Respir J 2002; 20: 376-382
Year: 2002
Influenza- and respiratory syncytial virus-associated mortality and hospitalisations
Source: Eur Respir J 2007; 30: 1158-1166
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept